In the pharmaceutical industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. In this video, Chief Architect, Imran Chaudhri answers some of the most frequently asked questions about the Pharma Research Hub.
Data silos and fragmented processes hinder drug safety practices for adverse event detection and reporting. Learn how MarkLogic breaks down data silos—enabling a complete view of data across pharmacovigilance operations that accelerates signal detection and simplifies regulatory reporting
With an immense amount of clinical data readily available for analytics, the challenge is to efficiently integrate disconnected data silos. Learn how data science and digital data technologies are empowering pharmaceutical organizations to bridge the gaps presented by these data silos.